Ligand Pharmaceuticals LGND EV / sales
EV / sales at other companies
Other financials
Where this comes from
Calculated from Ligand Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ligand Pharmaceuticals's ev / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ligand Pharmaceuticals's EV / sales?
- Ligand Pharmaceuticals (LGND) reported EV / sales of 14.1× in Q1 2026.
- How has Ligand Pharmaceuticals's EV / sales changed year-over-year?
- Ligand Pharmaceuticals's EV / sales increased by 29.2% year-over-year, from 10.9× to 14.1×.
- What is the long-term trend for Ligand Pharmaceuticals's EV / sales?
- Over 5 years (2020 to 2025), Ligand Pharmaceuticals's EV / sales has grown at a 8.6% compound annual growth rate (CAGR), from 8.8× to 13.2×.
- What does EV / sales mean?
- Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.